Related references
Note: Only part of the references are listed.Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
Hans-Christoph Diener et al.
CEPHALALGIA (2019)
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Peter J. Goadsby et al.
BRAIN (2019)
Targeted 5-HT1F Therapies for Migraine
Marta Vila-Pueyo
NEUROTHERAPEUTICS (2018)
Lasmiditan is an effective acute treatment for migraine A phase 3 randomized study
Bernice Kuca et al.
NEUROLOGY (2018)
Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis
Chris Cameron et al.
HEADACHE (2015)
Effectiveness of eletriptan in acute migraine: Primary care for Excedrin nonresponders
ML Diamond et al.
HEADACHE (2004)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
Share Paper
